Incyte Corporation (INCY)

Healthcare · Biotechnology · NASDAQ

S&P 500

Incyte Corporation (INCY) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $25.73B, a trailing price-to-earnings ratio of 14.2 and a free-cash-flow yield of 5.2%. Over the most recent reported fiscal year, revenue grew 21.2% and free cash flow per share grew 493.1%.

Market cap	$25.73B
Trailing P/E	14.2
FCF yield	5.2%
Revenue growth (YoY)	+21.2%
EPS growth (YoY)	+414.4%
FCF/share growth (YoY)	+493.1%
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live INCY data on Nama Insights →

Recent Congressional trades

Incyte Corporation trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Rob Bresnahan	House	Sell	$1,001 - $15,000	May 31, 2025
Shelley M Capito	Senate	Sell	$1,001 - $15,000	—
Shelley M Capito	Senate	Buy	$1,001 - $15,000	—